In previous studies about immunotherapy for lung cancer, it was reported that HPD occurred in 13.8% of patients due to the treatment of PD-1/PD-L1 inhibitors by Ferrara et al. [11], while Kim et al. reported an incidence of HPD with approximately 19% [15]. Here, CD274 is linked to lung cancer.